| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |